(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.3, 2003-03, pp. : 381-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p38 MAP Kinase Inhibitors as Anti inflammatory Agents

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 2082-2096

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of p38 kinase

By Hanson G.J.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 7, 1997-07 ,pp. : 729-733

Informa Healthcare

Access to resources Recommend Favorite

Recent Developments of p38 MAP Kinase Inhibitors as Antiinflammatory Agents Based on the Imidazole Scaffolds

Current Medicinal Chemistry, Vol. 20, Iss. 15, 2013-05 ,pp. : 1997-2016

Bentham Science Publishers

Access to resources Recommend Favorite

New inhibitors of p38 kinase

By Boehm J.C. Adams J.L.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 1, 2000-01 ,pp. : 25-37

Informa Healthcare

Access to resources Recommend Favorite

Allosteric p38 kinase inhibitors

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. : 1443-1448

Informa Healthcare

Access to resources Recommend Favorite